Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03247608 · ClinicalTrials.gov registry record · NA
ConnectedHeartHealth - Heart Failure Readmission Intervention
A NA study, sponsored by LifeBridge Health.
- Completed
- Registry status
- NA
- Development phase
- 30
- Enrollment target
NCT03247608 is a NA study that has completed, run by LifeBridge Health. The registered enrollment target is 30 participants.
The verdict
NCT03247608, a NA study, has completed, sponsored by LifeBridge Health.
- COMPLETED
- Registry status
- NA
- Development phase
- 30 participants
- Enrollment target
Study Summary
This is a single-center, pilot study that will evaluate the effectiveness of the AHA science based CarePlans and the Ambio Health technology in improving the risk adjusted 30 day readmissions rate, patient compliance, and biometrics. The study will also be used to assess the feasibility of similar heart failure transition programs in the future.
Interventions
- BEHAVIORAL Ambio Health Remote Monitoring
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2015-11 |
| Est. Completion | 2017-10-09 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03247608
The ClinicalTrials.gov registry entry for NCT03247608 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 30 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is LifeBridge Health, which has 14 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Ambio Health Remote Monitoring is the first listed.
NCT03247608 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03247608 about?
NCT03247608 is a clinical study titled "ConnectedHeartHealth - Heart Failure Readmission Intervention". This is a single-center, pilot study that will evaluate the effectiveness of the AHA science based CarePlans and the Ambio Health technology in improving the risk adjusted 30 day readmissions rate, patient compliance, and biometrics. The study will also be used to assess the feasibility of similar h...
What is the current status of trial NCT03247608?
This trial is currently completed. It is a NA study. The enrollment target is 30 participants. The study started on 2015-11. Estimated completion is 2017-10-09.
What interventions are being tested in trial NCT03247608?
The interventions under investigation include: Ambio Health Remote Monitoring (BEHAVIORAL).
Who is sponsoring clinical trial NCT03247608?
This trial is sponsored by LifeBridge Health, which has 14 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.